Amedisys (NASDAQ:AMED – Get Free Report) released its quarterly earnings data on Wednesday. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19), Briefing.com reports. The business had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The company’s revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.98 earnings per share.
Amedisys Trading Down 0.8 %
NASDAQ:AMED traded down $0.73 during trading hours on Friday, reaching $96.07. 80,891 shares of the stock were exchanged, compared to its average volume of 336,930. Amedisys has a twelve month low of $89.55 and a twelve month high of $98.95. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The business has a 50-day moving average of $96.73 and a two-hundred day moving average of $95.78. The company has a market capitalization of $3.15 billion, a price-to-earnings ratio of 34.57, a PEG ratio of 1.87 and a beta of 0.78.
Wall Street Analyst Weigh In
AMED has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target on the stock. in a research note on Monday, July 29th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $101.00 target price on shares of Amedisys in a research report on Thursday, July 25th. Four analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $100.67.
About Amedisys
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Further Reading
- Five stocks we like better than Amedisys
- What is a SEC Filing?
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- The Top 5 Performing S&P 500 Stocks YTD in 2024
- Roth IRA Calculator: Calculate Your Potential Returns
- L3Harris: Positioned for Gains With Trump’s Defense Policies
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.